These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7320696)

  • 21. Physicochemical surface properties of elementary bodies from different serotypes of chlamydia trachomatis and their interaction with mouse fibroblasts.
    Söderlund G; Kihlström E
    Infect Immun; 1982 Jun; 36(3):893-9. PubMed ID: 7095854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control mechanisms governing the infectivity of Chlamydia trachomatis for HeLa cells: the role of calmodulin.
    Murray A; Ward ME
    J Gen Microbiol; 1984 Jan; 130(1):193-201. PubMed ID: 6423768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control mechanisms governing the infectivity of Chlamydia trachomatis for HeLa cells: mechanisms of endocytosis.
    Ward ME; Murray A
    J Gen Microbiol; 1984 Jul; 130(7):1765-80. PubMed ID: 6470672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic energy dependency of
    Liang P; Rosas-Lemus M; Patel D; Fang X; Tuz K; Juárez O
    J Biol Chem; 2018 Jan; 293(2):510-522. PubMed ID: 29123027
    [No Abstract]   [Full Text] [Related]  

  • 25. Amino acid requirements of strains of Chlamydia trachomatis and C. psittaci growing in McCoy cells: relationship with clinical syndrome and host origin.
    Allan I; Pearce JH
    J Gen Microbiol; 1983 Jul; 129(7):2001-7. PubMed ID: 6631408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of capsaicin, an active component of chili pepper, on pathogenic chlamydial growth (Chlamydia trachomatis and Chlamydia pneumoniae) in immortal human epithelial HeLa cells.
    Yamakawa K; Matsuo J; Okubo T; Nakamura S; Yamaguchi H
    J Infect Chemother; 2018 Feb; 24(2):130-137. PubMed ID: 29132924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction of Chlamydia trachomatis with host cells: ultrastructural studies of the mechanism of release of a biovar II strain from HeLa 229 cells.
    Todd WJ; Caldwell HD
    J Infect Dis; 1985 Jun; 151(6):1037-44. PubMed ID: 3889172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence of multiple serovars of Chlamydia trachomatis to a common receptor on HeLa and McCoy cells is mediated by thermolabile protein(s).
    Vretou E; Goswami PC; Bose SK
    J Gen Microbiol; 1989 Dec; 135(12):3229-37. PubMed ID: 2636258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.
    Wolf K; Betts HJ; Chellas-Géry B; Hower S; Linton CN; Fields KA
    Mol Microbiol; 2006 Sep; 61(6):1543-55. PubMed ID: 16968227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlamydia trachomatis species-specific epitope detected on mouse biovar outer membrane protein.
    Stephens RS; Kuo CC
    Infect Immun; 1984 Sep; 45(3):790-1. PubMed ID: 6205997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural and polypeptide differences between envelopes of infective and reproductive life cycle forms of Chlamydia spp.
    Hatch TP; Allan I; Pearce JH
    J Bacteriol; 1984 Jan; 157(1):13-20. PubMed ID: 6690419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte proliferative responses to chlamydial antigens in human chlamydial eye infections.
    Mabey DC; Holland MJ; Viswalingam ND; Goh BT; Estreich S; Macfarlane A; Dockrell HM; Treharne JD
    Clin Exp Immunol; 1991 Oct; 86(1):37-42. PubMed ID: 1914234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and evaluation of a combination of chlamydial antigens to support the diagnosis of severe and invasive Chlamydia trachomatis infections.
    Forsbach-Birk V; Simnacher U; Pfrepper KI; Soutschek E; Kiselev AO; Lampe MF; Meyer T; Straube E; Essig A
    Clin Microbiol Infect; 2010 Aug; 16(8):1237-44. PubMed ID: 19723133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A method for the preparation of a Chlamydiae group-specific antigen on hela-229 cells infected with a strain of "Chlamydia trachomatis" for use in the complement fixation test (author's transl)].
    Colimon R; Ferchal F; Pérol Y
    Ann Microbiol (Paris); 1979 Oct; 130B(3):313-21. PubMed ID: 533072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control mechanisms governing the infectivity of Chlamydia trachomatis for hela cells: modulation by cyclic nucleotides, prostaglandins and calcium.
    Ward ME; Salari H
    J Gen Microbiol; 1982 Mar; 128(3):639-50. PubMed ID: 6281367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro.
    Wyrick PB; Knight ST; Gerbig DG; Raulston JE; Davis CH; Paul TR; Malamud D
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1335-44. PubMed ID: 9174195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disulfide-mediated interactions of the chlamydial major outer membrane protein: role in the differentiation of chlamydiae?
    Hackstadt T; Todd WJ; Caldwell HD
    J Bacteriol; 1985 Jan; 161(1):25-31. PubMed ID: 2857160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maraviroc, celastrol and azelastine alter
    Kuratli J; Leonard CA; Nufer L; Marti H; Schoborg R; Borel N
    J Med Microbiol; 2020 Dec; 69(12):1351-1366. PubMed ID: 33180014
    [No Abstract]   [Full Text] [Related]  

  • 39. Structural requirements of heparin binding to Chlamydia trachomatis.
    Chen JC; Zhang JP; Stephens RS
    J Biol Chem; 1996 May; 271(19):11134-40. PubMed ID: 8626658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between a trachoma strain of Chlamydia trachomatis and mouse fibroblasts (McCoy cells) in the absence of centrifugation.
    Lee CK
    Infect Immun; 1981 Feb; 31(2):584-91. PubMed ID: 7216462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.